Aggression  >>  Targretin oral (bexarotene oral)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Targretin oral (bexarotene oral) / ReXceptor
NCT00718770: A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression

Completed
1
10
US
Bexarotene, LGD-1069
University of Colorado, Denver, American Cancer Society, Inc., Eisai Inc.
Thyroid Cancer
01/13
02/13

Download Options